Q32 Bio
QTTB
86 hedge funds and large institutions have $756M invested in Q32 Bio in 2019 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 27 increasing their positions, 22 reducing their positions, and 8 closing their positions.
138% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 8
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
33% more capital invested
Capital invested by funds: $569M → $756M (+$187M)
23% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 22
8% more funds holding
Funds holding: 80 → 86 (+6)
0.64% more ownership
Funds ownership: 3.97% → 4.61% (+0.64%)
97% less call options, than puts
Call options by funds: $28K | Put options by funds: $924K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
+$30.2M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$7.17M |
| 3 |
JP Morgan Chase
New York
|
+$1.4M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$1.13M |
| 5 |
Millennium Management
New York
|
+$905K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Casdin Capital
New York
|
-$14.8M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$11.3M |
| 3 |
DM
Deerfield Management
New York
|
-$8.19M |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$4.44M |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$4.07M |
QTTB Hedge Fund Activity: Q4 2019 in Review
86 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q4 2019, worth a combined $756M — up 33% from $569M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new QTTB positions and 8 closed out — a net gain of 11 holders — while 27 added to existing stakes and 22 trimmed.
The largest buyer was RTW Investments, adding an estimated $30.2M. The largest seller was Casdin Capital, exiting entirely with an estimated $14.8M sold.
- 86 institutional investors held Q32 Bio (QTTB) as of Q4 2019, up from 80 in Q3 2019.
- Funds reported $756M of Q32 Bio stock for Q4 2019, up 33% quarter-over-quarter.
- 19 funds opened new Q32 Bio positions in Q4 2019 and 8 closed out, a net change of +11 holders.
- The largest Q32 Bio buyer in Q4 2019 was RTW Investments, an estimated $30.2M added.
- The largest Q32 Bio seller in Q4 2019 was Casdin Capital, an estimated $14.8M sold.
Based on aggregated 13F filings for Q4 2019.